Late-Stage Breast Cancer Patient Journey Feasibility: Qualitative Study

The Challenge

Pharmaceutical developer needed qualitative insights from late-stage breast cancer patients regarding treatment journeys, side effect tolerances, and clinical trial accessibility barriers.

Our Approach

We collaborated with medical patient advocacy organizations and clinic networks. All patients' diagnoses were validated by clinical coordinators, and interviews were hosted via HIPAA-compliant online rooms.

Results

80 completes. 100% medical verification. 25-day fieldwork timeline.

Project Specifications

• Markets Covered: Germany, France, Spain.
• Audience Recruited: Late-stage breast cancer patients and active caregivers.
• Compliance Level: HIPAA compliant data lockers with GDPR registries audited.
• Session Format: 60-Minute qualitative video interviews (IDIs).

Plan a Similar Study

Ready to execute high-integrity global B2B or consumer research? Contact our fieldwork consultants to design a tailored feasibility plan for your target audience.